Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Pax5: the guardian of B cell identity and function

Nature Immunology volume 8, pages 463–470 (2007)Cite this article

Abstract

The transcription factor Pax5 is essential for commitment of lymphoid progenitors to the B lymphocyte lineage. Pax5 fulfils a dual role by repressing B lineage 'inappropriate' genes and simultaneously activating B lineage–specific genes. This transcriptional reprogramming restricts the broad signaling capacity of uncommitted progenitors to the B cell pathway, regulates cell adhesion and migration, induces VH-DJH recombination, facilitates (pre-)B cell receptor signaling and promotes development to the mature B cell stage. Conditional Pax5 inactivation in early and late B lymphocytes revealed an essential role for Pax5 in controlling the identity and function of B cells throughout B lymphopoiesis. PAX5 has also been implicated in human B cell malignancies, as it is deregulated by chromosomal translocations in a subset of acute lymphoblastic leukemias and non-Hodgkin lymphomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Functional domains and interacting proteins of Pax5.
Figure 2: B cell lineage commitment by Pax5.
Figure 3: Pax5-dependent gene expression.
Figure 4: Pax5-dependent contraction of the Igh locus in pro-B cells.
Figure 5: Chromosomal translocations involving PAX5 in human B cell malignancies.

Similar content being viewed by others

References

  1. Busslinger, M. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22, 55–79 (2004).

    Article  CAS  Google Scholar 

  2. Weaver, D. & Baltimore, D. B lymphocyte-specific protein binding near an immunoglobulin κ-chain gene J segment. Proc. Natl. Acad. Sci. USA 84, 1516–1520 (1987).

    Article  CAS  Google Scholar 

  3. Waters, S.H., Saikh, K.U. & Stavnezer, J. A B-cell-specific nuclear protein that binds to DNA sites 5′ to immunoglobulin Sα tandem repeats is regulated during differentiation. Mol. Cell. Biol. 9, 5594–5601 (1989).

    Article  CAS  Google Scholar 

  4. Barberis, A., Widenhorn, K., Vitelli, L. & Busslinger, M. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev. 4, 849–859 (1990).

    Article  CAS  Google Scholar 

  5. Adams, B. et al. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6, 1589–1607 (1992).

    Article  CAS  Google Scholar 

  6. Liao, F., Birshtein, B.K., Busslinger, M. & Rothman, P. The transcription factor BSAP (NF-HB) is essential for immunoglobulin germ-line ε transcription. J. Immunol. 152, 2904–2911 (1994).

    CAS  PubMed  Google Scholar 

  7. Tian, J., Okabe, T., Miyazaki, T., Takeshita, S. & Kudo, A. Pax-5 is identical to EBB-1/KLP and binds to the VpreB and λ5 promoters as well as the KI and KII sites upstream of the Jκ genes. Eur. J. Immunol. 27, 750–755 (1997).

    Article  CAS  Google Scholar 

  8. Czerny, T., Schaffner, G. & Busslinger, M. DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. Genes Dev. 7, 2048–2061 (1993).

    Article  CAS  Google Scholar 

  9. Garvie, C.W., Hagman, J. & Wolberger, C. Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell 8, 1267–1276 (2001).

    Article  CAS  Google Scholar 

  10. Fitzsimmons, D. et al. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10, 2198–2211 (1996).

    Article  CAS  Google Scholar 

  11. Nutt, S.L., Morrison, A.M., Dörfler, P., Rolink, A. & Busslinger, M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17, 2319–2333 (1998).

    Article  CAS  Google Scholar 

  12. Eberhard, D. & Busslinger, M. The partial homeodomain of the transcription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and TATA-binding proteins. Cancer Res. 59, 1716s–1724s (1999).

  13. örfler, P. & Busslinger, M. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. EMBO J. 15, 1971–1982 (1996).

    Article  Google Scholar 

  14. Emelyanov, A.V., Kovac, C.R., Sepulveda, M.A. & Birshtein, B.K. The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J. Biol. Chem. 277, 11156–11164 (2002).

    Article  CAS  Google Scholar 

  15. Barlev, N.A. et al. A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription. Mol. Cell. Biol. 23, 6944–6957 (2003).

    Article  CAS  Google Scholar 

  16. Eberhard, D., Jiménez, G., Heavey, B. & Busslinger, M. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J. 19, 2292–2303 (2000).

    Article  CAS  Google Scholar 

  17. Nutt, S.L., Urbánek, P., Rolink, A. & Busslinger, M. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11, 476–491 (1997).

    Article  CAS  Google Scholar 

  18. Urbánek, P., Wang, Z.-Q., Fetka, I., Wagner, E.F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901–912 (1994).

    Article  Google Scholar 

  19. Nutt, S.L., Heavey, B., Rolink, A.G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401, 556–562 (1999).

    Article  CAS  Google Scholar 

  20. Rolink, A.G., Nutt, S.L., Melchers, F. & Busslinger, M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401, 603–606 (1999).

    Article  CAS  Google Scholar 

  21. Schaniel, C., Bruno, L., Melchers, F. & Rolink, A.G. Multiple hematopoietic cell lineages develop in vivo from transplanted Pax5-deficient pre-B I-cell clones. Blood 99, 472–478 (2002).

    Article  CAS  Google Scholar 

  22. öflinger, S. et al. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors. J. Immunol. 173, 3935–3944 (2004).

    Article  Google Scholar 

  23. Schaniel, C., Gottar, M., Roosnek, E., Melchers, F. & Rolink, A.G. Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones. Blood 99, 2760–2766 (2002).

    Article  CAS  Google Scholar 

  24. Heavey, B., Charalambous, C., Cobaleda, C. & Busslinger, M. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPα and GATA factors. EMBO J. 22, 3887–3897 (2003).

    Article  CAS  Google Scholar 

  25. Nutt, S.L. et al. Independent regulation of the two Pax5 alleles during B-cell development. Nat. Genet. 21, 390–395 (1999).

    Article  CAS  Google Scholar 

  26. Fuxa, M. & Busslinger, M. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity funtion. J. Immunol. 178, 3031–3037 (2007).

    Article  CAS  Google Scholar 

  27. Balciunaite, G., Ceredig, R., Massa, S. & Rolink, A.G.A. B220+ CD117+ CD19− hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur. J. Immunol. 35, 2019–2030 (2005).

    Article  CAS  Google Scholar 

  28. Halder, G., Callaerts, P. & Gehring, W. Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. Science 267, 1788–1792 (1995).

    Article  CAS  Google Scholar 

  29. Czerny, T. et al. Twin of eyeless, a second Pax-6 gene of Drosophila, acts upstream of eyeless in the control of eye development. Mol. Cell 3, 297–307 (1999).

    Article  CAS  Google Scholar 

  30. Souabni, A., Cobaleda, C., Schebesta, M. & Busslinger, M. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17, 781–793 (2002).

    Article  CAS  Google Scholar 

  31. Cotta, C.V., Zhang, Z., Kim, H-G. & Klug, C.A. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development. Blood 101, 4342–4346 (2003).

    Article  CAS  Google Scholar 

  32. Anderson, K. et al. Ectopic expression of Pax5 promotes self renewal of bi-phenotypic myeloid progenitors co-expressing myeloid and B-cell lineage associated genes. Blood (2007); published online 11 January 2007 (doi:10.1182/blood-2006-05-026021).

    Article  CAS  Google Scholar 

  33. O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21–31 (1999).

    Article  CAS  Google Scholar 

  34. Seet, C.S., Brumbaugh, R.L. & Kee, B.L. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A. J. Exp. Med. 199, 1689–1700 (2004).

    Article  CAS  Google Scholar 

  35. Hirokawa, S., Sato, H., Kato, I. & Kudo, A. EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells. Eur. J. Immunol. 33, 1824–1829 (2003).

    Article  CAS  Google Scholar 

  36. Fuxa, M. et al. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18, 411–422 (2004).

    Article  CAS  Google Scholar 

  37. Nera, K.-P. et al. Loss of Pax5 promotes plasma cell differentiation. Immunity 24, 283–293 (2006).

    Article  CAS  Google Scholar 

  38. Roessler, S. et al. Distinct promoters mediate the regulation of Ebf1 gene expression by IL-7 and Pax5. Mol. Cell. Biol. 27, 579–594 (2007).

    Article  CAS  Google Scholar 

  39. Hu, M. et al. Multilineage gene expression precedes commitment in the hematopoietic system. Genes Dev. 11, 774–785 (1997).

    Article  CAS  Google Scholar 

  40. Delogu, A. et al. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24, 269–281 (2006).

    Article  CAS  Google Scholar 

  41. Holmes, M.L., Carotta, S., Corcoran, L.M. & Nutt, S.L. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. Genes Dev. 20, 933–938 (2006).

    Article  CAS  Google Scholar 

  42. Tokoyoda, K., Egawa, T., Sugiyama, T., Choi, B.-I. & Nagasawa, T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20, 707–718 (2004).

    Article  CAS  Google Scholar 

  43. Tagoh, H. et al. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction. EMBO J. 25, 1070–1080 (2006).

    Article  CAS  Google Scholar 

  44. Kozmik, Z., Wang, S., Dörfler, P., Adams, B. & Busslinger, M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12, 2662–2672 (1992).

    Article  CAS  Google Scholar 

  45. Horcher, M., Souabni, A. & Busslinger, M. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14, 779–790 (2001).

    Article  CAS  Google Scholar 

  46. Ying, H., Healy, J.I., Goodnow, C.C. & Parnes, J.R. Regulation of mouse CD72 expression during B lymphocyte development. J. Immunol. 161, 4760–4767 (1998).

    CAS  PubMed  Google Scholar 

  47. Schebesta, M., Pfeffer, P.L. & Busslinger, M. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 17, 473–485 (2002).

    Article  CAS  Google Scholar 

  48. Hayashi, K., Yamamoto, M., Nojima, T., Goitsuka, R. & Kitamura, D. Distinct signaling requirements for Dμ selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression of B cell progenitors. Immunity 18, 825–836 (2003).

    Article  CAS  Google Scholar 

  49. Mikkola, I., Heavey, B., Horcher, M. & Busslinger, M. Reversion of B cell commitment upon loss of Pax5 expression. Science 297, 110–113 (2002).

    Article  CAS  Google Scholar 

  50. Bassing, C.H., Swat, W. & Alt, F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell 109 (suppl.), S45–S55 (2002).

    Article  CAS  Google Scholar 

  51. Johnston, C.M., Wood, A.L., Bolland, D.J. & Corcoran, A.E. Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. J. Immunol. 176, 4221–4234 (2006).

    Article  CAS  Google Scholar 

  52. Hesslein, D.G.T. et al. Pax5 is required for recombination of transcribed, acetylated, 5′ IgH V gene segments. Genes Dev. 17, 37–42 (2003).

    Article  CAS  Google Scholar 

  53. Kosak, S.T. et al. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296, 158–162 (2002).

    Article  CAS  Google Scholar 

  54. Roldán, E. et al. Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene. Nat. Immunol. 6, 31–41 (2005).

    Article  Google Scholar 

  55. Sayegh, C., Jhunjhunwala, S., Riblet, R. & Murre, C. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. Genes Dev. 19, 322–327 (2005).

    Article  CAS  Google Scholar 

  56. Su, I.-H. et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4, 124–131 (2003).

    Article  CAS  Google Scholar 

  57. Johnson, K. et al. B cell–specific loss of histone 3 lysine 9 methylation in the VH locus depends on Pax5. Nat. Immunol. 5, 853–861 (2004).

    Article  CAS  Google Scholar 

  58. Morshead, K.B., Ciccone, D.N., Taverna, S.D., Allis, C.D. & Oettinger, M.A. Antigen receptor loci poised for V(D)J rearrangement are broadly associated with BRG1 and flanked by peaks of histone H3 dimethylated at lysine 4. Proc. Natl. Acad. Sci. USA 100, 11577–11582 (2003).

    Article  CAS  Google Scholar 

  59. Zhang, Z. et al. Transcription factor Pax5 (BSAP) transactivates the RAG-mediated VH-to-DJH rearrangement of immunoglobulin genes. Nat. Immunol. 7, 616–624 (2006).

    Article  CAS  Google Scholar 

  60. Shaffer, A.L. et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17, 51–62 (2002).

    Article  CAS  Google Scholar 

  61. Lin, K.-I., Angelin-Duclos, C., Kuo, T.C. & Calame, K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 22, 4771–4780 (2002).

    Article  CAS  Google Scholar 

  62. Shaffer, A.L. et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation and cell cycle control. Immunity 13, 199–212 (2000).

    Article  CAS  Google Scholar 

  63. Reimold, A.M. et al. Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 183, 393–401 (1996).

    Article  CAS  Google Scholar 

  64. Akashi, K., Traver, D., Miyamoto, T. & Weissman, I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193–197 (2000).

    Article  CAS  Google Scholar 

  65. Xie, H., Ye, M., Feng, R. & Graf, T. Stepwise reprogramming of B cells into macrophages. Cell 117, 663–676 (2004).

    Article  CAS  Google Scholar 

  66. Hsu, C.L. et al. Antagonistic effect of CCAAT enhancer-binding protein-α and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors. Proc. Natl. Acad. Sci. USA 103, 672–677 (2006).

    Article  CAS  Google Scholar 

  67. Pasqualucci, L. et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341–346 (2001).

    Article  CAS  Google Scholar 

  68. Busslinger, M., Klix, N., Pfeffer, P., Graninger, P.G. & Kozmik, Z. Deregulation of PAX-5 by translocation of the Eμ enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc. Natl. Acad. Sci. USA 93, 6129–6134 (1996).

    Article  CAS  Google Scholar 

  69. Lida, S. et al. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88, 4110–4117 (1996).

    CAS  Google Scholar 

  70. Morrison, A.M. et al. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. Blood 92, 3865–3878 (1998).

    CAS  PubMed  Google Scholar 

  71. Poppe, B. et al. PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements. Genes Chromosom. Cancer 44, 218–223 (2005).

    Article  CAS  Google Scholar 

  72. Souabni, A., Jochum, W. & Busslinger, M. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus. Blood 109, 281–289 (2007).

    Article  CAS  Google Scholar 

  73. Mullighan, C.G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature advance online publication, 7 March 2007 (doi:10.1038/nature05690).

    Article  CAS  Google Scholar 

  74. Cazzaniga, G. et al. The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case. Cancer Res. 61, 4666–4670 (2001).

    CAS  PubMed  Google Scholar 

  75. Strehl, S., König, M., Dworzak, M.N., Kalwak, K. & Haas, O.A. PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13). Leukemia 17, 1121–1123 (2003).

    Article  CAS  Google Scholar 

  76. Bousquet, M. et al. A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on the wild-type PAX5. Blood (2007); published online 19 December 2006 (doi:10.1182/blood-2006-05-025221).

    Article  CAS  Google Scholar 

  77. Weng, A.P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269–271 (2004).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank S. Nutt and T. Jenuwein for comments on the manuscript. Supported by Boehringer Ingelheim (M.B.), the Austrian Industrial Research Promotion Fund (M.B.), a Spanish 'Ramon y Cajal' investigator grant (C.C.) and Fondo de Investigaciónes Sanitarias (PI04/0261; C.C.).

Author information

Author notes

  1. César Cobaleda

    Present address: Present address: Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain.,

Authors and Affiliations

  1. Research Institute of Molecular Pathology, Vienna Biocenter, Dr. Bohr-Gasse 7, Vienna, A-1030, Austria

    César Cobaleda, Alexandra Schebesta, Alessio Delogu & Meinrad Busslinger

Authors
  1. César Cobaleda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexandra Schebesta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alessio Delogu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meinrad Busslinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meinrad Busslinger.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cobaleda, C., Schebesta, A., Delogu, A. et al. Pax5: the guardian of B cell identity and function. Nat Immunol 8, 463–470 (2007). https://doi.org/10.1038/ni1454

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni1454

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing